Search our Database of Scientific Publications and Authors

I’m looking for a
    Cutaneous lymphoma of the tarsus in cats: 23 cases (2000-2012).
    J Am Vet Med Assoc 2014 Jun;244(12):1429-34
    Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.
    Objective: To determine features of lymphoma of the tarsus in cats.

    Design: Multi-institutional retrospective study.

    Animals: 23 cats with cutaneous lymphoma of the tarsus.

    Procedures: Veterinary oncologists were requested to submit cases fitting the following criteria: histologically or cytologically confirmed lymphoma with a location at or near the tarsus and described as subcutaneous or mass-like. Data regarding breed, sex, age, FeLV and FIV status, and reason for evaluation were collected. Results of staging tests, location of the tumor, immunophenotype, and histopathologic description were recorded. Type of treatments, outcome, survival time, presence or absence of progressive disease, and cause of death or reason for euthanasia were also recorded.

    Results: Most cats were older, with a median age of 12 years (range, 7 to 18 years). No association with positive retroviral status was found. Popliteal lymph node involvement at diagnosis was reported in 5 cats, and a suspicion of lymphoma at a different site on the basis of results of abdominal ultrasonography was reported in 4 cats. Treatments were variable and included corticosteroids alone (n = 2), chemotherapy (9), radiation and chemotherapy (7), or surgery with or without chemotherapy (5). Thirteen cats were reported to have lymphoma at a different site at the time of last follow-up, death, or euthanasia. Median survival time for all cats in the study was 190 days (range, 17 to 1,011 days).

    Conclusions And Clinical Relevance: Results suggested that tarsal lymphoma is an uncommon manifestation of lymphoma in cats, and in this study was most commonly nonepitheliotropic and of high grade as determined on histologic evaluation. Systemic involvement was identified; therefore, thorough staging is recommended prior to initiating treatment. Future studies are warranted to evaluate effective treatment protocols.

    Similar Publications

    Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997)
    J Am Vet Med Assoc 1998 Oct;213(8):1144-9
    Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis 95616-8734, USA.
    Objective: To determine clinical and pathologic findings in cats with alimentary malignant lymphoma and results of treatment with a combination of prednisone, L-asparaginase, vincristine, cyclophosphamide, doxorubicin, and methotrexate.

    Design: Retrospective study.

    Animals: 21 cats with alimentary malignant lymphoma. Read More
    Response rates and survival times for cats with lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol: 38 cases (1996-2003).
    J Am Vet Med Assoc 2005 Oct;227(7):1118-22
    Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0126, USA.
    Objective: To determine response rates and survival times for cats with lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol.

    Design: Retrospective study.

    Animals: 38 cats with lymphoma. Read More
    Therapy for Australian cats with lymphosarcoma.
    Aust Vet J 2001 Dec;79(12):808-17
    Department of Veterinary Clinical Sciences, Faculty of Veterinary Science, The University of Sydney, New South Wales.
    Objective: To determine the response of Australian cats with lymphosarcoma to chemotherapy and/or surgery in relation to patient and tumour characteristics, haematological and serum biochemical values and retroviral status.

    Design: Prospective study of 61 client-owned cats with naturally-occurring lymphosarcoma subjected to multi-agent chemotherapy and/or surgery.

    Procedure: An accepted chemotherapy protocol utilising l-asparaginase, vincristine, cyclophosphamide, doxorubicin, methotrexate and prednisolone was modified and used to treat 60 cats with lymphosarcoma. Read More
    Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
    J Am Vet Med Assoc 2008 Apr;232(8):1200-5
    Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
    Objective: To determine clinical activity and toxic effects of lomustine when used to treat cats with mast cell tumors (MCTs).

    Design: Retrospective case series.

    Animals: 38 cats with measurable, histologically or cytologically confirmed MCTs treated with lomustine at a dosage > or = 50 mg/m(2). Read More